Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘hedge fund:740’

Healthcare Careers That Require a Master’s Degree

13G Filing: Foresite Capital Fund III, L.P. and Cymabay Therapeutics Inc. (CBAY)

Cymabay Therapeutics Inc. (NASDAQ:CBAY): Jim Tananbaum’s Foresite Capital Fund III, L.P. filed an amended 13D. You can check out Foresite Capital......(read more)
Jim Tananbaum - Foresite Capital

13G Filing: Foresite Capital Fund III, L.P. and Verona Pharma PLC (VRNA)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
Jim Tananbaum - Foresite Capital

13G Filing: Foresite Capital Fund III, L.P. and Tocagen Inc (TOCA)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
Healthcare Careers That Require a Master’s Degree

Nanostring Technologies (NSTG): Foresite Capital Growing More Bullish

Jim Tananbaum‘s Foresite Capital has recently increased its stake in Nanostring Technologies Inc (NASDAQ:NSTG), lifting it to roughly 5.9% of......(read more)
Jim Tananbaum - Foresite Capital

Foresite Capital Betting It All On These Four Healthcare Stocks

Jim Tananbaum’s Foresite Capital has filed its latest 13F with the Securities and Exchange Commission for the reporting period of March 31, disclosing......(read more)